cell cycle control Flashcards
What types of tumours are associated with people that inherit an inactivated copy of RB1 ie part of the RB1 cancer syndrome?
Primitive neuroectodermal tumours (PNET) in the CNS
Soft tissue and osteosarcomas
Melanomas
Lung and bladder carcinomas
What does complete loss of RB1 result in?
This leads to benign retinomas with fleurettes which may remain stable for life or progress to retinoblastomas showing that loss of pRb function can deregulate the cell cycle but cannot by itself generate cancer as the senescent state is activated and maintained p16 and p130 however this senescent state is associated with low level genetic instability
Escape from this senescent state requires further (epi)genetic events which induce clonal expansion and malignancy indicated by the presence of necrotic, apoptotic and mitotic cells
This malignant state is associated with high level genetic instability
What proteins are part of the RB family?
These proteins control the restriction site and include pRb and the pocket proteins, p130 and p107
The function through control of the transcription factors of the E2F family and are themselves regulated through cyclin dependant kinases
What is the function of pRb?
This inhibits the activating E2Fs which drive transcription from many genes involved in S phase progression
What is the function of p130 and p107?
These activate the inhibitory E2Fs (E2F4,5)
What must occur to the pocket proteins before cells can enter the cell cycle?
The pocket proteins must be inactivated by CDKs
Cyclin D-CDK4 phosphorylates the pocket proteins leading to their dissociation from E2F proteins and the initiation of transcription where the activator E2Fs induce transcription of their own genes and of cyclins E and A
How do Mitogens activate CDK4 and 6?
Through inducing synthesis of cyclin D1, formation of cyclin D1-CDK4 complexes
There is nuclear translocation of cyclin D-CDK4 complexes
Stabilisation of cyclin D through PI3k/Akt inhibition of glycogen synthase kinase 3beta which phosphorylates cyclin D on T286 leading to nuclear export and degradation
What occurs as the cyclin D-CDK4 dimer become abundant in cells?
It sequesters p21 and p27 in quiescent cells, these proteins bind to and inhibit any cyclin E-CDK2 that may be present which normally bind to an inhibit Cyclin E-CDK2
This allows CDK2-E to become active and when the p27/Cyclin E-CDK2 ratio is decreased to a critical threshold it will phosphorylate free p27 on T187 triggering its degradation
How can cell cycle blocking occur through p27?
If mitogens are removed and cyclin D concentrations decrease, p16 or p15 is induced, binds to CDK4 disrupting cyclin-DCDK4-p27 complexes allowing release of p27 so it can bind to cyclin E-CDK2 leading to its inhibition
What are the mechanisms which may lead to inactivation of the R point in cancer?
Genetic mutation or deletion of RB1 or RB2 (in the nuclear localisation sequences causing cytoplasmic rather than nuclear degradation) Increased pRb degradation MYC-induced Id2 proteins Viral targeting of Rb proteins Over expression of cyclin D1 Excess Cdk4 Loss of p16
How can increased pRb degradation occur?
The LXCXE motif protein gankyrin is over expressed in liver cancers it increases proliferation rate, promotes anchorage independent proliferation and enhances tumorigenicitiy
It binds to pRb to increase its phosphorylation and accelerate its degradation it is a subunit of the 26S proteasome
How do MYC-induced Id2 proteins lead to inactivation of the R point?
RB-/- mice die before birth with delayed differentiation of haematopoietic and neuronal cells because pRb binds and inihibits Id2 which suppresses differentiation
Neuroblatomas with amplified N-MYC oncogenes express Id2 in molar excess over pRb overcoming cell cycle arrest
How does viral targeting of proteins deregulate the cell cycle?
The HHV-8 cyclin K is a variation of the cyclin theme, Cyclin K-CDK6 phosphorylates pRb and also p27kip1 on T187 to cause its debradation and activate CDK2
This unusual Cyclin K-CDK6 does not require p27kip1 for nuclear translocation unlike cyclin d-CDKs and remains active
How can over expression of cyclin D1 lead to deregulation of the R point?
This may occur as a result of gene amplification or translocation. Mantle cell lymphomas possess a t(11;14) activating the cyclin D1 gene they may also lose pRb or p16 suggesting that there may be varying degrees of R point disruption
How can excess Cdk4 activity occur?
Gene amplification or mutations that prevent p16 binding